Australia Veterinary Healthcare Market Size (2024 - 2029)

Australia Veterinary Healthcare Market Analysis

The Australia Animal Healthcare Market is expected to reach a CAGR of 9.75% over the forecast period (2022-2027).

The Veterinary Industry in Australia has been impacted by the effect of coronavirus, especially on the livestock segment. An unprecedented rise in pet ownership across the country has been seen post-COVID-19. There has been an increasing focus on Veterinary Telemedicine in the country, which is likely to have a positive impact on the market. According to the article titled 'Impact of the COVID-19 Pandemic on the Welfare of Animals in Australia' published in January 2021, some organizations, including Animal Health Australia (AHA), the Australian Veterinary Association (AVA), and the Royal Society for the Prevention of Cruelty to Animals (RSPCA) Australia, contacted the Australian Federal Department of Agriculture, Water and Environment to request that veterinarians be classified as essential services. The Australian Veterinary Association (AVA) also re-affirmed that veterinarians could conduct telemedicine consultations in the context of the COVID-19 pandemic, leading to increased veterinary teleconsultations and telepharmacy during the pandemic. This development is anticipated to increase the adoption of tele Veterinary Services, driving market growth.

The Veterinary Services Industry in Australia is projected to be led by advancements in health technology, leading to innovations in Animal Healthcare and increasing animal adoption in Australia, coupled with animal health spending. According to the Animal Medicines Australia 2021 Survey published in October 2021, Australian households own an estimated total of 6.3 million dogs and 4.9 million cats. The high adoption of pets in Australian households eventually leads to increased adoption of Veterinary Healthcare services in Australia, thereby driving market growth.

Furthermore, a rise in collaborations between key market players and investments from Veterinary Pharmaceutical Companies in Australia is also expected to drive the growth of this market. For instance, in November 2021, Merck Sharp & Dohme Corp (MSD Animal Health Australia), a division of Merck & Co., Inc., joined VetDB as an investor. In VetDB's third round of seed funding, MSD Animal Health joins the company's previous investors. VetDB's continuous growth and nationwide dissemination of its revolutionary medical technology will be aided by this financing. The rising investments by companies in the development of veterinary health technology are therefore expected to contribute to the market growth over the forecast period.

Therefore, the rising adoption of pets and the rise in investments in technological advancements in veterinary health, among other Veterinary Industry Trends, are expected to drive the growth of this market. However, there is a shift in the trend toward the use of counterfeit Animal Health Products, which are usually cheap, of low quality, and produced without adequate testing. These act as restraints for the market's growth.

Australia Veterinary Healthcare Industry Segmentation

As per the scope of this report, the Australia veterinary healthcare market is growing, and it comprises therapeutic and diagnostic products and solutions for companion and farm animals. Companion animals can be tamed or adopted for companionship or as house/office guards, and farm animals are raised for meat and milk-related products. Companion animals include canines, felines, and equines. Farm animals include bovine, poultry, and porcine. The Australia Veterinary Healthcare Market is segmented on The Basis of Product (Therapeutics And Diagnostics) and Animal Type (Dogs And Cats, Horses, Ruminants, Swine, Poultry, and Other Animals). The report offers the value (in USD million) for the above segments.